MedTrace Logo

BDNF Levels After Bacopa

NCT03974399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2021-03-02

No results posted yet for this study

Summary

Brain-derived neurotrophic factor (BDNF) is a well-known neurotrophic factor important for learning, memory, and synaptogenesis. Healthy activities such as exercise are believed to raise BDNF, while stress is associated with lower BDNF. What is not well understood is if there are certain supplements that may raise BDNF over time. Bacopa monnieri is well characterized nutraceutical. Animal and pre-clinical data support multiple beneficial mechanisms, including raising BDNF and increasing synaptogenesis. Additionally, small studies have shown Bacopa enhances cognition and improves mood. We would like to investigate if BDNF level changes in people after starting Bacopa.

Conditions

  • Memory

Interventions

DIETARY_SUPPLEMENT

Bacopa Monnieri

subjects will take Bacopa Monnieri daily for 3 months

Sponsors & Collaborators

  • Florida Department of Health

    collaborator OTHER_GOV

  • Roskamp Institute Inc.

    lead OTHER

Principal Investigators

  • Andrew Keegan, M.D. · The Roskamp Institute Inc

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2020-04-01
Completion
2020-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03974399 on ClinicalTrials.gov